BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX), announced today that the U.S. Food and Drug Administration (FDA) has approved the third drug to be offered in the new BD Simplist™ line of ready-to-administer prefilled generic injectables. The third BD Simplist product to launch is […]

Spartan Bioscience today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance permitting marketing of the Spartan RX CYP2C19 System. It provides genetic results in less than 60 minutes from a non-invasive cheek swab. The automated system is indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by […]

Franklin Lakes, NJ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, supports the U.S. Food and Drug Administration’s (FDA’s) proposed reclassification of rapid influenza detection tests. A hearing, held on June 13th by FDA’s CDRH Microbiology Devices Advisory Committee Meeting, examined the FDA’s proposal to reclassify rapid influenza detection […]

BOSTON, MA – Partners HealthCare today announced that it has started offering doctors and patients the option of whole genome sequencing, analysis and interpretation. The test, available to patients across the nation, will offer physicians and patients the ability to better diagnose and treat disease. Partners is the one of the first health care systems […]

Melbourne, Australia,: Agenix Limited (ASX: AGX) is pleased to announce that it has entered into a co-operation and cross-licensing agreement with Scotland based Arrayjet Limited, a specialist with existing expertise and intellectual property in microarray technology. The agreement commits the partners to undertake R & D both in Scotland and Australia to jointly develop a […]